Related Experiment Video

Updated: Jun 17, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

The role of SRC-3 in human breast cancer

Ondrej Gojis1, Bharath Rudraraju, Mihir Gudi

  • 1Department of Pathology, Third Faculty of Medicine, Charles University Prague, Prague 10, 10000, Czech Republic.

Nature Reviews. Clinical Oncology
|December 23, 2009
PubMed

Insights

Estrogen receptor alpha (ERalpha) and its co-regulators, particularly steroid receptor co-activator-3 (SRC-3), are crucial in breast cancer development and progression. Understanding their roles may improve treatment strategies.

Area of Science:

  • Molecular biology
  • Endocrinology
  • Oncology

Background:

  • Nuclear receptors are key regulators of physiological and disease processes.
  • Estrogen receptor alpha (ERalpha) is vital in normal biology and breast cancer pathogenesis.
  • Transcriptional co-regulators are recruited by ERalpha to control gene expression.

Purpose of the Study:

  • To review the role of steroid receptor co-activator-3 (SRC-3) in breast cancer.
  • To investigate SRC-3's involvement in breast cancer risk, outcome, and endocrine therapy response.

Main Methods:

  • Literature review focusing on nuclear receptors, ERalpha, and co-regulators.
  • Analysis of studies investigating SRC-3 amplification in breast cancer.
  • Examination of SRC-3's impact on breast cancer progression and treatment.

Main Results:

  • SRC-3 is frequently amplified in breast cancer.
  • SRC-3 plays a significant role in breast cancer progression.
  • SRC-3 influences patient outcomes and response to endocrine therapy.

Conclusions:

  • SRC-3 is a critical co-regulator in ERalpha-mediated gene expression relevant to breast cancer.
  • Targeting SRC-3 may offer new therapeutic strategies for breast cancer patients.

More Related Videos

Three-Dimensional (3D) Tumor Spheroid Invasion Assay12:19

Three-Dimensional (3D) Tumor Spheroid Invasion Assay

Published on: May 1, 2015

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...